2021 Revenues ($USD) : $1,050,582,000
2021 R&D spend : $79,838,000
2021 Number of Employees : 2,800
Fiscal Year End : 12/31/2020
Key People : Chris Barry, CEO; Aviva McPherron, VP, information technology; Dale Wolf, SVP, global operations; Kyle Malone, VP, clinical, medical and regulatory affairs; Massimo Calafiore, chief commercial officer; Matt Harbaugh, EVP and CFO; Michael Farrington, VP, corporate marketing, brand and communication; Nathaniel Sisitsky, SVP, general counsel and corporate secretary; Ryan Donahoe, chief technology officer; Sean Freeman, SVP, strategy and corporate development.

About the company: NuVasive over the summer announced the commercial launch of the Pulse spinal surgical automation platform after it received its latest 510(k) clearance and CE mark approval. Pulse integrates radiation reduction, imaging enhancement, rod bending, navigation, intraoperative neuromonitoring, spinal alignment tools and more into a single platform. The spine technology company’s portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. –CN